Theriva Biologics Inc. (TOVX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
10,123,900
EV to revenue ratio (TTM)
9.96
EV to ebitda
1.719
Financial Performance
Revenue (TTM)
300,000
Gross profit (TTM)
300,000
EBITDA
-11,963,000
Profitability
Operating margin (TTM)
-4,022.00%
Profit margin
0.00%
Return on assets (TTM)
-21.30%
Return on equity (TTM)
-101.90%
Per Share Metrics
Revenue per share (TTM)
0.01
EPS
1.44
Diluted EPS (TTM)
1.44
Book value
0.27
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
0.153
Trailing P/E
0.153
Forward P/E
PEG ratio
Price to sales ratio (TTM)
33.75
Price to book ratio (TTM)
0.884
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
1.149